Cargando…
Autophagy- An emerging target for melanoma therapy
Melanoma accounts for only 5% of all cancers but is the leading cause of skin cancer death due to its high metastatic potential. Patients with metastatic melanoma have a 10-year survival rate of less than 10%. While the clinical landscape for melanoma is evolving rapidly, lack of response to therapi...
Autores principales: | Ndoye, Abibatou, Weeraratna, Ashani T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972082/ https://www.ncbi.nlm.nih.gov/pubmed/27583134 http://dx.doi.org/10.12688/f1000research.8347.1 |
Ejemplares similares
-
In the Wnt-er of life: Wnt signalling in melanoma and ageing
por: Kaur, Amanpreet, et al.
Publicado: (2016) -
A Series of BRAF- and NRAS-Driven Murine Melanoma Cell Lines with Inducible Gene Modulation Capabilities
por: Bok, Ilah, et al.
Publicado: (2021) -
A glitch in the matrix: Age-dependent changes in the extracellular matrix facilitate common sites of metastasis
por: Marino, Gloria E., et al.
Publicado: (2020) -
Completing the Great Unfinished Symphony of Cancer Together: The Importance of Immigrants in Cancer Research
por: Morin, Pat J., et al.
Publicado: (2020) -
G9a: An Emerging Epigenetic Target for Melanoma Therapy
por: Flesher, Jessica L., et al.
Publicado: (2021)